Annual Book Value
$21.29 M
-$17.17 M-44.64%
December 31, 2023
Summary
- As of February 7, 2025, CRDL annual book value is $21.29 million, with the most recent change of -$17.17 million (-44.64%) on December 31, 2023.
- During the last 3 years, CRDL annual book value has risen by +$10.89 million (+104.60%).
- CRDL annual book value is now -64.39% below its all-time high of $59.79 million, reached on December 31, 2021.
Performance
CRDL Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$7.72 M
-$3.49 M-31.16%
September 30, 2024
Summary
- As of February 7, 2025, CRDL quarterly book value is $7.72 million, with the most recent change of -$3.49 million (-31.16%) on September 30, 2024.
- Over the past year, CRDL quarterly book value has dropped by -$3.49 million (-31.16%).
- CRDL quarterly book value is now -87.09% below its all-time high of $59.79 million, reached on December 1, 2021.
Performance
CRDL Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
CRDL Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.6% | -31.2% |
| 3 y3 years | +104.6% | -31.2% |
| 5 y5 years | +30.2% | -31.2% |
CRDL Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.4% | at low | -87.1% | at low |
| 5 y | 5-year | -64.4% | +104.6% | -87.1% | at low |
| alltime | all time | -64.4% | +838.2% | -87.1% | +410.9% |
Cardiol Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.72 M(-31.2%) |
| Jun 2024 | - | $11.21 M(-24.5%) |
| Mar 2024 | - | $14.85 M(-30.3%) |
| Dec 2023 | $21.29 M(-44.6%) | $21.29 M(-17.0%) |
| Sep 2023 | - | $25.65 M(-12.3%) |
| Jun 2023 | - | $29.24 M(-13.2%) |
| Mar 2023 | - | $33.68 M(-12.4%) |
| Dec 2022 | $38.46 M(-35.7%) | $38.46 M(-10.4%) |
| Sep 2022 | - | $42.91 M(-12.0%) |
| Jun 2022 | - | $48.78 M(-12.0%) |
| Mar 2022 | - | $55.44 M(-7.3%) |
| Dec 2021 | $59.79 M | - |
| Dec 2021 | - | $59.79 M(+162.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $22.80 M(-16.2%) |
| Jun 2021 | - | $27.21 M(+88.3%) |
| Mar 2021 | - | $14.45 M(+38.8%) |
| Dec 2020 | $10.41 M(-7.3%) | $10.41 M(-38.0%) |
| Sep 2020 | - | $16.79 M(-12.2%) |
| Jun 2020 | - | $19.11 M(+116.4%) |
| Mar 2020 | - | $8.83 M(-21.4%) |
| Dec 2019 | $11.23 M(-31.3%) | $11.23 M(-10.7%) |
| Sep 2019 | - | $12.57 M(-15.7%) |
| Jun 2019 | - | $14.92 M(-9.2%) |
| Mar 2019 | - | $16.43 M(+0.5%) |
| Dec 2018 | $16.35 M(+620.6%) | $16.35 M(-758.5%) |
| Sep 2018 | - | -$2.48 M(-209.4%) |
| Dec 2017 | $2.27 M | $2.27 M |
FAQ
- What is Cardiol Therapeutics annual book value?
- What is the all time high annual book value for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual book value year-on-year change?
- What is Cardiol Therapeutics quarterly book value?
- What is the all time high quarterly book value for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly book value year-on-year change?
What is Cardiol Therapeutics annual book value?
The current annual book value of CRDL is $21.29 M
What is the all time high annual book value for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual book value is $59.79 M
What is Cardiol Therapeutics annual book value year-on-year change?
Over the past year, CRDL annual book value has changed by -$17.17 M (-44.64%)
What is Cardiol Therapeutics quarterly book value?
The current quarterly book value of CRDL is $7.72 M
What is the all time high quarterly book value for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly book value is $59.79 M
What is Cardiol Therapeutics quarterly book value year-on-year change?
Over the past year, CRDL quarterly book value has changed by -$3.49 M (-31.16%)